GUERBET

Company Introduction:

Guerbet is a global pharmaceutical company specializing in medical imaging. It develops, produces, and markets contrast agents, medical devices, and digital solutions for diagnostic and interventional radiology. Headquartered in France, Guerbet is dedicated to improving patient diagnosis and treatment worldwide through innovative solutions.

Status in India:

Guerbet India Private Limited operates as a trading and marketing company.

Elaboration:

Guerbet India Private Limited is a subsidiary of the global Guerbet group. Its primary role in India is to manage the sales, marketing, distribution, and commercial operations of Guerbet's medical imaging products, including contrast agents, within the Indian market. This involves importing finished products from Guerbet's manufacturing facilities located in other countries and supplying them to hospitals and healthcare professionals across India. Guerbet India does not have a manufacturing plant or factory in India; its operations are focused on market access, sales, and distribution.

Guerbet India manufactures or sells products primarily in the field of medical imaging. Their product portfolio includes:

Contrast Media for Magnetic Resonance Imaging (MRI):

Dotarem (gadoterate meglumine)

Contrast Media for Computed Tomography (CT) and Interventional Radiology:

Xenetix (iobitridol)

Optiray (ioversol)

Contrast Media for Interventional Radiology and Lymphography:

Lipiodol Ultra-Fluid (ethiodized oil)

Medical Devices for Contrast Media Injection:

OptiVantage Dual-Head CT Injectors

FlowSens CT Injectors

Associated consumables such as syringes and connecting tubes

Digital Solutions:

Contrast & Care (a contrast media injection data management solution)